Owlet (OWLT) Fundamentals 2026 — Revenue Analysis | SniperIQ
Owlet (OWLT) is a US-listed Healthcare company in Medical - Devices with a market capitalization of $98M, trading at $5.42 on the NYSE. This SniperIQ fundamentals page covers Owlet's valuation, profitability (net margin -43.0%), revenue (
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Owlet's market cap?
Owlet (OWLT) has a market capitalization of approximately $98M, trading at $5.42 on the NYSE. Market cap moves with the live share price.
What is Owlet's P/E ratio?
Owlet's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 0.5x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Owlet?
Owlet runs a net profit margin of -43.0%, a gross margin of 50.9%, and an operating margin of -10.3%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Owlet generate?
Owlet reported revenue of
Does Owlet pay a dividend?
Owlet does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Owlet financially healthy?
Owlet carries a debt-to-equity ratio of 0.52x and a current ratio of 1.71x, with a market beta of 1.84. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Owlet a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Owlet (OWLT) the key facts are: market cap $98M, revenue
Track Owlet's full fundamentals live
Get Owlet's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.